AXNX 70.98 (+0%)
US05465P1012Medical Devices & InstrumentsMedical Devices

Axonics Modulation Technologies (AXNX) Stock Highlights

70.98 | +0%
2024-12-21 02:45:44
Axonics Modulation Technologies Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.

Statistics

Range Today
70.98 70.98
Volume Today 0
Range 1 Year
55.09 71.05
Volume 1 Year 171.74M
Range 3 Year
38.41 79.92
Volume 3 Year 474.8M
Range 10 Year
11.95 79.92
Volume 10 Year 826.11M

Highlights

Market Capitalization 3.6B (mid)
Floating Shares 50.45M
Current Price 70.98
Price To Earnings -3.52K
Price To Revenue 7.61
Price To Book 5.42
Earnings Per Share -0.02
Payout Ratio 0%

Performance

Latest 0%
1 Month +1.08%
3 Months +3.39%
6 Months +4.77%
1 Year +25.61%
3 Years +14.84%
5 Years +144.76%
10 Years +342.24%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.